Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 8-K Event Material agreement · New debt or obligation · Other events
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 4/A Open-market buy Director bought 500 shares at $7.30 ($3,650)
  4. 8-K Event Executive or director change
  5. 4 Open-market buy Director bought 3,650 shares at $7.30 ($26,645)
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Other events
  8. 8-K Event Results of operations
  9. 10-Q Report Quarterly Report
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $8.50 ($8,500)
  12. 4 Open-market buy Director bought 79,410 shares at $8.50 ($674,985)
  13. 4 Open-market buy President & CEO bought 23,529 shares at $8.50 ($199,997)
  14. 4 Open-market buy Director bought 5,000 shares at $8.50 ($42,500)
  15. 4 Open-market buy 10% owner bought 411,765 shares at $8.50 ($3,500,003)
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Open-market buy 10% owner bought 308,824 shares at $8.50 ($2,625,004)
  18. 8-K Event Material agreement · Other events
  19. 424B4 Offering Prospectus
  20. EFFECT Other Notice of Effectiveness

Page 43 of 50 · 1,000 filings